Pharma Mar, S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHMMF research report →
About the company
Pharma Mar, S. A. is a biopharmaceutical firm dedicated to the discovery, development, manufacturing, and commercialization of bioactive compounds derived from marine organisms, primarily targeting oncology applications.
- CEO
- Jose Maria Fernandez Sousa-Faro
- IPO
- 2016
- Employees
- 500
- HQ
- Madrid, ES
Price Chart
- Market Cap
- $1.38B
- P/E
- 17.24
- P/S
- 6.15
- P/B
- 5.52
- EV/EBITDA
- 20.02
- Div Yield
- 1.00%
- Gross Margin
- 92.66%
- Op Margin
- 26.12%
- Net Margin
- 35.70%
- ROE
- 35.74%
- ROIC
- 19.05%
- Revenue
- $221.31M · 26.57%
- Net Income
- $74.96M · 186.92%
- EPS
- $4.30 · 188.59%
- Op Income
- $40.26M
- FCF YoY
- 561.19%
- 52W High
- $110.40
- 52W Low
- $77.41
- 50D MA
- $98.92
- 200D MA
- $93.96
- Beta
- 0.41
- Avg Volume
- 261
Get TickerSpark's AI analysis on PHMMF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PHMMF coverage
Recent articles, reports, and earnings notes.
No research on PHMMF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PHMMF report →Similar companies
Peers in the same neighborhood.